ClinicalTrials.gov
public full text
Public Domain
Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis Patients
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Modulation of Inflammation by Medium Cut Off Membranes#1100603
- Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer#869828
- Afatinib in Advanced Refractory Urothelial Cancer#918630
- Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer#864901
- Understand the Association Between Peritoneal Dialysis Status and Gene Polymorphisms of VEGF and KDR#980026
Record · ID 300361
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive